Insiders who reported open-market trades in the last 12 months at the companies 5AM Ventures V, L.P. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Kush Parmar - $3.65M in TRDA purchases and sales in the last 12 months
5AM Ventures V, L.P. is an investment firm, tracked as 10% Owner of Entrada Therapeutics, Inc. (TRDA). InsiderAlpha holds 5 primary Form 4 filings for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has 5AM Ventures V, L.P. submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has 5AM Ventures V, L.P. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 13 open-market sales ($4.07M) across all tracked filings.
5AM Ventures V, L.P. is 10% Owner of Entrada Therapeutics, Inc. (TRDA). 5 SEC Form 4 filings on record going back to 2025, most recently on 10 August 2026. Most recent open-market trade: sold $358K of TRDA on 10 August 2026. Lifetime open-market sales: $4.07M.
Recent transactions
13
The latest 13 SEC Form 4 transactions reported by 5AM Ventures V, L.P..
InsiderAlpha's records for 5AM Ventures V, L.P. go back to 2025: 5 primary Form 4 filings, an average of 2.5 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
